Abstract

We have recently identified a specific binding site for the tachykinin peptide substance P (SP) fragment SP 1–7 in the rat spinal cord. This site appeared very specific for SP 1–7 as the binding affinity of this compound highly exceeded those of other SP fragments. We also observed that endomorphin-2 (EM-2) exhibited high potency in displacing SP 1–7 from this site. In the present work using a [ 3H]-labeled derivative of the heptapeptide we have identified and characterized [ 3H]-SP 1–7 binding in the rat ventral tegmental area (VTA). Similarly to the [ 3H]-SP 1–7 binding in the spinal cord the affinity of unlabeled SP 1–7 to the specific site in VTA was significantly higher than those of other SP fragments. Further, the tachykinin receptor NK-1, NK-2 and NK-3 ligands showed no or negligible binding to the identified site. However, the μ-opioid peptide (MOP) receptor agonists DAMGO, EM-1 and EM-2 did, and significant difference was observed in the binding affinity between the two endomorphins. As recorded from displacement curves the affinity of EM-2 for the SP 1–7 site was 4–5 times weaker than that for SP 1–7 but about 5 times higher than that of EM-1. The opioid receptor antagonists naloxone and naloxonazine showed weak or negligible binding. It was concluded that the specific site identified for SP 1–7 binding in the rat VTA is distinct from the MOP receptor although it exhibits high affinity for EM-2.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.